maslinic acid has been researched along with Triple Negative Breast Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Grover, A; Jain, R | 1 |
1 other study(ies) available for maslinic acid and Triple Negative Breast Neoplasms
Article | Year |
---|---|
Maslinic acid differentially exploits the MAPK pathway in estrogen-positive and triple-negative breast cancer to induce mitochondrion-mediated, caspase-independent apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Female; Humans; MAP Kinase Signaling System; MCF-7 Cells; Membrane Potential, Mitochondrial; Molecular Docking Simulation; Reactive Oxygen Species; Receptors, Estrogen; Triple Negative Breast Neoplasms; Triterpenes | 2020 |